Mental health is on the decline all over the world.
In fact, as reported by Sky News, a report authored by the Lancet-World Psychiatric Association Commission estimates that, “around 5 per cent of the adult population around the world in any year is living with depression. In high-income countries, about half of people suffering from depression are not diagnosed or treated, and this rises to 80-90% in low and middle-income countries.”
“The pandemic, the study says, has created additional challenges, with ‘social isolation, bereavement, uncertainty, hardship, and limited access to healthcare taking a serious toll on the mental health of millions.’”
With that, some of the top companies working to alleviate mental health issues include NeonMind Biosciences (CSE:NEON)(OTC:NMDBF), COMPASS Pathways (NASDAQ:CMPS), Cybin Inc. (NEO:CYBN)(NYSE:CYBN), Field Trip Health Ltd. (TSX:FTRP)(NASDAQ:FTRP), and Mind Medicine Inc. (NASDAQ:MNMD)(NEO:MMED).